Neurology

The CGTLive Neurology specialty topic page houses video interviews with key opinion leaders in the field of neurology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for neurologic disorders and diseases. It also contains up-to-date clinical news coverage in the field of gene and cell therapy for central nervous system disorders.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – June 27, 2025

June 27th 2025

Review top news and interview highlights from the week ending June 27, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – June 25, 2025
Around the Helix: Cell and Gene Therapy Company Updates – June 25, 2025

June 25th 2025

FDA Announces Investigation of Deaths Following Treatment With Sarepta’s DMD Gene Therapy Elevidys
FDA Announces Investigation of Deaths Following Treatment With Sarepta’s DMD Gene Therapy Elevidys

June 25th 2025

Linda Marbán, PhD, the CEO of Capricor Therapeutics
FDA Indicates AdComm Not Currently Required for Capricor’s BLA for DMD Cardiomyopathy Cell Therapy Deramiocel

June 24th 2025

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – June 20, 2025

June 20th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.